콘텐츠로 건너뛰기
Merck
  • Toxic epidermal necrolysis-like cutaneous lupus erythematosus: A series of three patients.

Toxic epidermal necrolysis-like cutaneous lupus erythematosus: A series of three patients.

Acta dermato-venereologica (2010-02-20)
Claudia G C Cisneros, Ricardo Romiti, Cláudia G Santi, Valéria Aoki, Neusa Y S Valente, Marcello M S Nico
초록

Toxic epidermal necrolysis-like lesions have been described in the setting of lupus erythematosus, and have been considered as a specific hyperacute variant of cutaneous lupus erythematosus, with features different from classical drug-related toxic epidermal necrolysis. We report here a series of three patients with lupus erythematosus who presented with severe worsening of their cutaneous disease in a toxic epidermal necrolysis-like fashion. We compared these cases with cases reported previously. Based on this discussion, we speculate that some of these patients may have classical drug-related toxic epidermal necrolysis rather than lupus erythematosus-related toxic epidermal necrolysis.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Chloroquine diphosphate salt, powder or crystals, 98.5-101.0% (EP)
Supelco
Chloroquine phosphate, Pharmaceutical Secondary Standard; Certified Reference Material